CN103006558A - 一种Cabazitaxel脂质微球注射液及其制备方法 - Google Patents
一种Cabazitaxel脂质微球注射液及其制备方法 Download PDFInfo
- Publication number
- CN103006558A CN103006558A CN2012104844946A CN201210484494A CN103006558A CN 103006558 A CN103006558 A CN 103006558A CN 2012104844946 A CN2012104844946 A CN 2012104844946A CN 201210484494 A CN201210484494 A CN 201210484494A CN 103006558 A CN103006558 A CN 103006558A
- Authority
- CN
- China
- Prior art keywords
- injection
- cabazitaxel
- oil
- phospholipid
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012104844946A CN103006558A (zh) | 2011-12-21 | 2012-11-24 | 一种Cabazitaxel脂质微球注射液及其制备方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110431332.1 | 2011-12-21 | ||
CN201110431332 | 2011-12-21 | ||
CN2012104844946A CN103006558A (zh) | 2011-12-21 | 2012-11-24 | 一种Cabazitaxel脂质微球注射液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103006558A true CN103006558A (zh) | 2013-04-03 |
Family
ID=47956025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012104844946A Pending CN103006558A (zh) | 2011-12-21 | 2012-11-24 | 一种Cabazitaxel脂质微球注射液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103006558A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105560182A (zh) * | 2016-02-04 | 2016-05-11 | 索安克(上海)投资有限公司 | 注射用卡巴他赛组合物及其制备方法 |
WO2016177346A1 (zh) * | 2015-05-06 | 2016-11-10 | 江苏天士力帝益药业有限公司 | 一种卡巴他赛脂肪乳注射剂及其制备方法和用途 |
CN104306333B (zh) * | 2014-09-28 | 2017-08-04 | 沈阳药科大学 | 一种卡巴他赛脂质微球注射液及其制备方法 |
WO2022068585A1 (zh) * | 2020-09-30 | 2022-04-07 | 北京诺康达医药科技股份有限公司 | 脂质微球组合物及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102210652A (zh) * | 2010-04-06 | 2011-10-12 | 山东靶点药物研究有限公司 | 一种larotaxel磷脂复合物的脂质微球注射液及其制备方法 |
-
2012
- 2012-11-24 CN CN2012104844946A patent/CN103006558A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102210652A (zh) * | 2010-04-06 | 2011-10-12 | 山东靶点药物研究有限公司 | 一种larotaxel磷脂复合物的脂质微球注射液及其制备方法 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104306333B (zh) * | 2014-09-28 | 2017-08-04 | 沈阳药科大学 | 一种卡巴他赛脂质微球注射液及其制备方法 |
WO2016177346A1 (zh) * | 2015-05-06 | 2016-11-10 | 江苏天士力帝益药业有限公司 | 一种卡巴他赛脂肪乳注射剂及其制备方法和用途 |
JP2018515484A (ja) * | 2015-05-06 | 2018-06-14 | 江蘇天士力帝益薬業有限公司 | カバジタキセル脂肪乳剤注射剤、その調製方法およびその使用 |
RU2716218C2 (ru) * | 2015-05-06 | 2020-03-10 | Цзянсу Тасли Дии Фармасьютикал Ко., Лтд. | Состав для инъекции на основе жировой эмульсии кабазитаксела, способ его получения и применение |
CN105560182A (zh) * | 2016-02-04 | 2016-05-11 | 索安克(上海)投资有限公司 | 注射用卡巴他赛组合物及其制备方法 |
CN105560182B (zh) * | 2016-02-04 | 2017-07-11 | 索安克(上海)投资有限公司 | 注射用卡巴他赛组合物及其制备方法 |
WO2022068585A1 (zh) * | 2020-09-30 | 2022-04-07 | 北京诺康达医药科技股份有限公司 | 脂质微球组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Scioli Montoto et al. | Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects | |
Rafiei et al. | Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile | |
Liu et al. | Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells | |
Bernabeu et al. | Paclitaxel-loaded PCL–TPGS nanoparticles: In vitro and in vivo performance compared with Abraxane® | |
Bahari et al. | The impact of variables on particle size of solid lipid nanoparticles and nanostructured lipid carriers; a comparative literature review | |
Jiang et al. | Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin | |
Jing et al. | A novel polyethylene glycol mediated lipid nanoemulsion as drug delivery carrier for paclitaxel | |
Zeng et al. | Aloe derived nanovesicle as a functional carrier for indocyanine green encapsulation and phototherapy | |
CN104306333B (zh) | 一种卡巴他赛脂质微球注射液及其制备方法 | |
CN110302175B (zh) | 一种含疏水空腔硫辛酸纳米胶囊及其制备方法和应用 | |
CN106619588B (zh) | 一种含辅酶q10的自微乳型营养组合物、制备方法及用途 | |
CN103006558A (zh) | 一种Cabazitaxel脂质微球注射液及其制备方法 | |
Vu et al. | Development and characterization of soy lecithin liposome as potential drug carrier systems for codelivery of letrozole and paclitaxel | |
Sun et al. | Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions | |
WO2019007019A1 (zh) | 一种补骨脂素聚合物纳米粒制剂以及制备方法 | |
Chen et al. | Preparation and characterization of paclitaxel palmitate albumin nanoparticles with high loading efficacy: an in vitro and in vivo anti-tumor study in mouse models | |
JP2013509361A (ja) | ステロイド化合物を中間担体としてタクソールサブマイクロエマルション | |
JP2022160584A (ja) | オキサリプラチンを含む経口用薬物送達組成物及びその製造方法 | |
Lu et al. | Characterization and evaluation of an oral microemulsion containing the antitumor diterpenoid compound ent-11alpha-hydroxy-15-oxo-kaur-16-en-19-oic-acid | |
CN107137353A (zh) | 一种注射用卡巴他赛脂质体剂型及其制备方法 | |
CN105125495B (zh) | 聚酯类材料担载双硫仑的纳米粒及其应用、药物制剂及其应用 | |
Chen et al. | Which polymer is more suitable for etoposide: A comparison between two kinds of drug loaded polymeric micelles in vitro and in vivo? | |
CN111195230A (zh) | 一种制备柔性脂质体的方法 | |
CN102210652A (zh) | 一种larotaxel磷脂复合物的脂质微球注射液及其制备方法 | |
Yang et al. | Optimization and evaluation of lipid emulsions for intravenous co-delivery of artemether and lumefantrine in severe malaria treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20151216 Address after: Xinghu Street Industrial Park of Suzhou city in Jiangsu province 215125 BioBAY No. 218 building A3 room 318 Applicant after: Suzhou Leina Pharmaceutical Research Development Co., Ltd. Applicant after: CHANGZHOU BADIAN MEDICINE TECHNOLOGY CO., LTD. Address before: Xinghu Street Industrial Park of Suzhou city in Jiangsu province 215125 BioBAY No. 218 building A3 room 318 Applicant before: Suzhou Leina Pharmaceutical Research Development Co., Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20161108 Address after: 213000 Jiangsu city of Changzhou province's new No. 7 North Road Applicant after: CHANGZHOU BADIAN MEDICINE TECHNOLOGY CO., LTD. Address before: Xinghu Street Industrial Park of Suzhou city in Jiangsu province 215125 BioBAY No. 218 building A3 room 318 Applicant before: Suzhou Leina Pharmaceutical Research Development Co., Ltd. Applicant before: CHANGZHOU BADIAN MEDICINE TECHNOLOGY CO., LTD. |
|
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130403 |
|
WD01 | Invention patent application deemed withdrawn after publication |